MetLife Inc. (NYSE: MET) is 5.24% higher on its value in year-to-date trading and has touched a low of $22.85 and a high of $53.28 in the current 52-week trading range. The MET stock was last observed hovering at around $49.58 in the last trading session, with the day’s loss setting it -0.17% off its average median price target of $53.50 for the next 12 months. It is also 17.65% off the consensus price target high of $60.00 offered by 15 analysts, but current levels are -2.94% lower than the price target low of $48.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $49.41, the stock is 5.87% and 9.34% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.41 million and changing -0.34% at the moment leaves the stock 27.62% off its SMA200. MET registered -5.65% loss for a year compared to 6-month gain of 33.76%. The firm has a 50-day simple moving average (SMA 50) of $47.06 and a 200-day simple moving average (SMA200) of $40.74.
The stock witnessed a 3.98% loss in the last 1 month and extending the period to 3 months gives it a 23.99%, and is 5.24% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.10% over the week and 2.41% over the month.
MetLife Inc. (MET) has around 49000 employees, a market worth around $44.62B and $65.70B in sales. Current P/E ratio is 8.11 and Fwd P/E is 7.98. Profit margin for the company is 8.50%. Distance from 52-week low is 116.24% and -7.26% from its 52-week high. The company has generated returns on investments over the last 12 months (8.30%).
MetLife Inc. (MET) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for MetLife Inc. (MET) is a “Overweight”. 15 analysts offering their recommendations for the stock have an average rating of 2.00, where 4 rate it as a Hold and 0 think it is a “Overweight”. 10 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
MetLife Inc. is expected to release its quarterly report on 05/05/2021 and quarterly earnings per share for the current quarter are estimated at $1.48 with sales reaching $16.04B over the same period.The EPS is expected to grow by 23.30% this year, but quarterly earnings will post -7.50% year-over-year. Quarterly sales are estimated to shrink -11.60% in year-over-year returns.
MetLife Inc. (MET) Top Institutional Holders
1,334 institutions hold shares in MetLife Inc. (MET), with 137.29M shares held by insiders accounting for 15.25% while institutional investors hold 91.28% of the company’s shares. The shares outstanding are 908.70M, and float is at 762.65M with Short Float at 1.93%. Institutions hold 77.35% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 68.4 million shares valued at $2.54 billion. The investor’s holdings represent 7.60% of the MET Shares outstanding. As of Sep 29, 2020, the second largest holder is Dodge & Cox Inc with 66.74 million shares valued at $2.48 billion to account for 7.42% of the shares outstanding. The other top investors are Vanguard Group, Inc. (The) which holds 60.97 million shares representing 6.78% and valued at over $2.27 billion, while Price (T.Rowe) Associates Inc holds 4.50% of the shares totaling 40.45 million with a market value of $1.5 billion.
MetLife Inc. (MET) Insider Activity
A total of 49 insider transactions have happened at MetLife Inc. (MET) in the last six months, with sales accounting for 5 and purchases happening 44 times. The most recent transaction is an insider sale by Kinney Catherine R, the company’s Director. SEC filings show that Kinney Catherine R sold 3,657 shares of the company’s common stock on Aug 13 at a price of $39.50 per share for a total of $0.14 million. Following the sale, the insider now owns 47264.0 shares.
MetLife Inc. disclosed in a document filed with the SEC on Feb 10 that Goulart Steven J (EVP & Chief Investment Officer) sold a total of 14,200 shares of the company’s common stock. The trade occurred on Feb 10 and was made at $51.60 per share for $0.73 million. Following the transaction, the insider now directly holds 0.11 million shares of the MET stock.
MetLife Inc. (MET): Who are the competitors?
The company’s main competitors (and peers) include Aegon N.V. (AEG) that is trading -4.26% down over the past 12 months. American Financial Group Inc. (AFG) is -15.59% down on the 1-year trading charts. Short interest in the company’s stock has risen 14.52% from the last report on Nov 12, 2020 to stand at a total of 12.6 million short shares sold with a short interest ratio of 2.54.